Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.
Eur J Haematol. 2023 Nov;111(5):715-721. doi: 10.1111/ejh.14065. Epub 2023 Jul 27.
Eur J Haematol. 2023.
PMID: 37501508
Free article.
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Mattsson A, Sylvan SE, Asklid A, Wiggh J, Winqvist M, Lundin J, Mansouri L, Rosenquist R, Johansson H, Österborg A, Hansson L.
Mattsson A, et al.
Br J Haematol. 2020 Nov;191(3):426-432. doi: 10.1111/bjh.17032. Epub 2020 Aug 10.
Br J Haematol. 2020.
PMID: 32779190
Free PMC article.
Item in Clipboard
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.
Hansson L, Asklid A, Diels J, Eketorp-Sylvan S, Repits J, Søltoft F, Jäger U, Österborg A.
Hansson L, et al.
Ann Hematol. 2017 Oct;96(10):1681-1691. doi: 10.1007/s00277-017-3061-3. Epub 2017 Jul 31.
Ann Hematol. 2017.
PMID: 28762081
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite